NQD

Cardiac C-Reactive Protein, Antigen, Antiserum, And Control

Product code
NQD
Device name
Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Device class
Class 2
21 CFR
21 CFR 866.5270
Medical specialty
Immunology
Marketing pathway
510(K)
Flag
Third-party review eligible
510(k) clearances (last 3 years)
2
Summaries archived here
2 (direct download)
510(k) clearances (all years, FDA)
19 (all years; only the last 3 years are listed here)

FDA classification definition

In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (2)

Last three years. Most recent: 2026-04-02.

NumberDecision dateApplicantDevice nameSummary
K2600262026-04-02Roche DiagnosticsTina-quant Cardiac high sensitivity CRP IIIPDF
K2332422024-01-18Siemens Healthcare Diagnostics, Inc.Atellica® CH High Sensitivity C-Reactive Protein 2 (…PDF

2 summaries are archived here for direct download.

Official FDA classification page: NQD
Classification and pathway per current FDA publications. Data from openFDA (CC0).